MedPath

Observation of Cough Variant Asthma Treated in Combination of Chanqin Granules.

Phase 1
Conditions
Cough Variant Asthma
Interventions
Drug: Chanqin granules
Registration Number
NCT03319043
Lead Sponsor
Shanghai University of Traditional Chinese Medicine
Brief Summary

This single-center, randomized, double-blind, placebo-controlled trial was undertaken at an outpatient clinic in Shuguang Hospital. Newly diagnosed cough variant asthma adult patients with the T.C.M. pattern of pathogenic-wind are randomly divided into treatment and control group, with 60 patients in each group. Clinical observation of the Respiratory Impedance and Inflammation in Cough Variant Asthma adults reated in Combination of Chanqin Granules.

Detailed Description

This single-center, randomized, double-blind, placebo-controlled trial was undertaken at an outpatient clinic in Shuguang Hospital. Newly diagnosed cough variant asthma adult patients with the T.C.M. pattern of pathogenic-wind are randomly divided into treatment and control group, with 60 patients in each group. All patients enrolled are treated with Budesonide + Formoterol Fumarate dry power (160/4.5ug bid) for inhalation. The treatment group are given additional Chanqin granulate (10g bid) and placebo granulate for controlled group. Investigators hypothesis that Chanqin granules may reduce day \& night cough score as well as the respiratory impedance, inflammation statues, and improve T.C.M. syndrome after 8 weeks of treatment.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  1. Diagnosis of cough variant asthma according to Western medicine

  2. Diagnosis of cough with pathogenic wind syndrome according to TCM

  3. Aged between 18 to 70 years, regardless of gender, race or educational and economic status

  4. The cough symptom should last for at least 8 weeks

  5. Willingness to participate and to sign the informed consent form

Exclusion Criteria
  1. Patients with history of smoking (or quite smoking for less than 6 months)
  2. Systemic use of corticosteroids in the past 4 weeks
  3. Upper or lower respiratory tract infection in the past 4 weeks
  4. Incapable of corporation with spirometry and FeNO test
  5. Other chronic respiratory disease eg: COPD, pulmonary cirrhosis
  6. Women who are pregnant or preparing to become pregnant or breast feeding women

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
treatment groupChanqin granulespatients are treated with Budesonide + Formoterol Fumarate dry powder (160/4.5ug bid) for inhalation and additional Chanqin granules 10g three times a day. All granules will be taken orally with 200 ml warm water.
controlled groupChanqin granulespatients enrolled in the research are treated with Budesonide + Formoterol Fumarate dry powder (160/4.5ug bid) for inhalation and Chanqin analogous granules. All granules will be taken orally with 200 ml warm water.
Primary Outcome Measures
NameTimeMethod
Impulse Oscillometry2 week

The patients will be seated comfortably in a nonswivel chair. Nose clips were applied and a special mouthpiece will be used. For Impulse Oscillometry measurements (MasterScreen, CareFusion, San Diego, California) are performed according to the protocols of the European Respiratory Society. Patients will be advised to cradle their cheeks with their hands. Patients are allowed to breathe normally while the loudspeaker delivere intermittent multi-frequency impulses over a minimum of a 30-s period. A trained technician will guide and assist the patient during the procedure, which involved three to five sinusoidal readings, depending on the incidence of cough, swallowing, and holding of breath. The recordings with the best coherence at frequencies from 5 to 30 Hz will be chosen. The technician is also trained to capture subclinical leaks through the mouthpiece, and leaky recordings will be discarded. The Impulse Oscillometry parameters measured are Zrs、R5、R20、X5.

Secondary Outcome Measures
NameTimeMethod
Cough severity2 week

Cough severity is measured by a validated verbal category-descriptive (VCD) scores which patients reported. =The scale has 6 discrete values: 0=no cough; 1=one short period of mild cough without hardship; 2=some short periods of cough without much hardship; 3=frequent coughing that does not affect normal daily life or sleep; 4=serious coughing that is very frequent and interferes with normal daily life or sleep; 5=distressing continuous coughing that did not stop for 24 h.

Exhaled nitric oxide2 week

Exhaled nitric oxide is measured using a portable analyzer, the NIOX MINO (Aerocrine AB, Solna, Sweden). Participants performe a 10 seconds slow steady exhalation. Three successive recordings at 1-minute intervals, expressed as parts per billion (ppb), are made.

Trial Locations

Locations (1)

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine

🇨🇳

Shanghai, Shanghai, China

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
🇨🇳Shanghai, Shanghai, China
XUAN XUAN, Master
Contact
+86-13611899735
chen77xuan@aliyun.com
Wei Zhang, Master
Contact
+86-13023153956
zhangw1190@sina.com
Qi CHEN, Master
Principal Investigator
GuiHua XU, Master
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.